Breaking News, Promotions & Moves

AGC Biologics Appoints Two SVPs

Axel Schleyer and Christoph Winterhalter will serve as SVP of Business Development, North America and Europe, respectively

AGC Biologics has appointed Axel Schleyer as senior vice president of Business Development, North America, and Christoph Winterhalter as senior vice president of Business Development, Europe. Mr. Schleyer and Mr. Winterhalter will report to Robert Broeze, chief business officer.   Mr. Schleyer brings more than 17 years of leadership experience in business development and key account management for pharmaceutical, biotechnology, and contract manufacturing organizations. He most recently s...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters